Companies
RNS
Signals
Macro
Squawk
Research
Indices
Ticker TV
Events
Commodities
Currencies

· Data products

RNS Signals Research Squawk Macro TV Events

Developer Portal Market data Services

Overview Central banks RNS Book a demo

‌

Spyre Therapeutics, Inc. (SYRE) on NASDAQ GLOBAL SELECT MARKET | Ticker

/Exchanges/XNGS/SYRE

Spyre Therapeutics, Inc.

XNGS:SYRE — listed on NASDAQ GLOBAL SELECT MARKET

Overview Financials

About Spyre Therapeutics, Inc.

Website: aegleabio.com
Issuer profile: All listings

Financial Summary

Operating Profit:	-$209.6M
Profit After Tax:	-$155.2M
Total Assets:	$777.8M
Shareholders' Equity:	$715.2M
Current Ratio:	13.25
Operating Cash Flow:	-$169.3M

As at Dec 202510 years of data

Listing details

Symbol: SYRE
Venue: NASDAQ GLOBAL SELECT MARKET
Segment MIC: XNGS
ISIN: US00773J2024
Trading currency: USD